Research Article

Prevalence of reported drug allergy and its impact on Beta lactam use with financial and health implications

Joanna Lukawska*, Abirami Murugesh-Warre#, Ranu Malhin#, Yogini Jani, Christopher Corrigan, David Walker and Harsha Kariyawasam

Published: 22 August, 2017 | Volume 1 - Issue 1 | Pages: 028-035

Background:While recognition and documentation of true drug allergy is critically important, most physicians acknowledge that its prevalence is likely overestimated, often on the basis of historical, sometimes anecdotal evidence. Correct or not, once applied, drug allergy labels may result in altered, potentially inferior therapy, increased costs and prolonged hospitalisation.

Objective:Estimate the point prevalence, accuracy and symptomatology of self-reported drug allergy in a typical, large NHS Acute Trust adult inpatient population. In the subset with penicillin allergy (PA), estimate additional management costs from the use of alternative antibiotics and readmission rates in the previous 5 years.

Methods:Data on self-reported drug allergies were extracted from 440 adult inpatient prescription charts over a 4 month period. Where penicillin allergy (PA) was reported, alternative antibiotic regimens were recorded and their additional costs calculated. Hospital electronic records were used to assess readmission rates of PA patients.

Results:194/440 inpatients (44.5%) reported at least one drug allergy. Antibiotic allergy was most commonly reported (51%), followed by analgesic (23%) and antiemetic (12%) allergy. PA accounted for 76% of reported antibiotic allergy. The commonest reported symptoms were cutaneous (42%) and gastrointestinal (18%). Where antibiotic therapy was required for patients with PA to manage acute infections, Ciprofloxacin, Clarithromycin, Teicoplanin, Clindamycin and Cefuroxime were the most commonly employed alternatives. Extrapolation of these figures to include the entire Trust inpatient population suggested that the use of alternative antibiotics in PA patients incurred additional annual expenditure of £268,000. Further, 87% of PA patients had been admitted more than once in the preceding 5 years, with 74% requiring further courses of antibiotics during these admissions.

Conclusion:Self-reported drug allergy, and in particular PA, is common in hospital inpatient populations and, in addition to the potentially unnecessary hazards to individual patients resulting from the use of alternative antibiotics, results in a considerable additional financial burden to the healthcare system. This problem could be eliminated by the provision of a nationwide and equitable tertiary Allergy service.

Read Full Article HTML DOI: 10.29328/journal.haard.1001004 Cite this Article Read Full Article PDF


Penicillin; Beta lactams; Allergy; Antibiotic; Cost; Readmission; Self-reported; Drug allergy


  1. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001; 137: 765-770. Ref.: https://goo.gl/NSJVU3
  2. Classen DC, Pestonik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospitalized patients. JAMA. 1991; 266: 2847-2851. Ref.: https://goo.gl/GV1cBb
  3. Rademaker M, Oakley A, Dufill MB. Cutaneous adverse drug reactions in a hospital setting. N Z Med J. 1995; 108: 165-166. Ref.: https://goo.gl/86CLgx
  4. Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survery. Allergy. 1997; 52: 388-393. Ref.: https://goo.gl/yNG1GA
  5. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents- a 6 year series from Chandigarh, India. J Postgrad Med. 2001; 47: 388-393. Ref.: https://goo.gl/cyzFfa
  6. Thong BY, Leong KP, Tang CY, Chng HH. Drug Allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol. 2003; 90: 342-347. Ref.: https://goo.gl/nyjuSv
  7. Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol. 2003; 149: 1018-1022. Ref.: https://goo.gl/Lg23pk
  8. Hernández-Salazar A, Rosales SP, Rangel-Frausto S, Criollo E, Archer-Dubon C, et al. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients. Arch Med Res. 2006; 37: 899-902. Ref.: https://goo.gl/eKT2So
  9. Macy E, Contreras R. Healthcare use of serious infection prevalence associated with penicillin ‘allergy’ in hospitalized patients: a cohort study. J Allergy Clin Immunol. 2014; 133: 790-796. Ref.: https://goo.gl/NyVNQC
  10. Park MA, Matesic D, Markus PJ, Li JTC. Female sex as a risk factor for penicillin allergy. Ann Allergy Asthma Immunol. 2007; 99: 54-58. Ref.: https://goo.gl/udaN4i
  11. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H. Hospital consumption of antibiotics in 15 European counties: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother. 2006; 58: 159-167.
  12. Pumphrey RS, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet. 1999; 353: 1157-1158. Ref.: https://goo.gl/2brVZ4
  13. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004; 39: 1267-1284. Ref.: https://goo.gl/k85jz5
  14. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2013; 41: 580-637. Ref.: https://goo.gl/D8hdSK
  15. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50: 133-164. Ref.: https://goo.gl/wSDsPS
  16. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171: 388-416. Ref.: https://goo.gl/A1fbvv
  17. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infectious. Clin Infect Dis. 2012; 54: 132-173. Ref.: https://goo.gl/bDchcc
  18. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Disease Society of America. Clin Infect Dis. 2014; 59: 10-52. Ref.: https://goo.gl/d7JXf3
  19. Jeffries MN, Narayan PP, Shuster JE, Schramm GE. Consequences of avoiding beta-lactams in patients with b-lactam allergies. J Allergy Clin Immunol. 2016; 137: 1148-1153. Ref.: https://goo.gl/G2euqr
  20. Picard M, Begin P, Bouchard H, Cloutier J, Lacombe-Barrios J, et al. Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital. J Allergy Clin Immunol Pract. 2013; 1: 252-257. Ref.: https://goo.gl/ycXTQp
  21. Li M, Krishna MT, Razaq S, Pillay D. A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of ‘penicillin allergy’ in a UK teaching hospital. J Clin Pathol. 2014; 67: 1088-1092. Ref.: https://goo.gl/qPVd68
  22. NHS Business Services Authority, NHS Prescription Services. NHS Electronic Drug Tariff. [Internet]. nhsbsa.nhs.uk
  23. British National Formulary. [Internet]. medicinescomplete.com. [Cited October 5, 2016]. Ref.: https://goo.gl/GmWRHa
  24. Gomes E, Cardoso MF, Praça F, Gomes L, Mariño E. Self-reported drug allergy in a general adult Portugese population. Clin Exp Allergy. 2004; 34: 1597-1601. Ref.: https://goo.gl/eBQG5p
  25. MacPherson RD, Willcox C, Chow C, Wang A. Anaesthetist’s responses to patients’ self-reported drug allergies. Br J Anaesth. 2006; 97: 634-639. Ref.: https://goo.gl/XV3AFL
  26. Jones TA, Como JA. Assesment of medication errors that involved drug allergies at a university hospital. Pharmacotherapy. 2003; 23: 855-860. Ref.: https://goo.gl/UbQHhH
  27. Shenfield GM, Robb T, Duguid M. Recording previous adverse drug reactions-a gap in the system. Br J Clin Pharmacol. 2001; 51: 623-626. Ref.: https://goo.gl/gw7xJk
  28. Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA. 1993; 270: 2456-2463. Ref.: https://goo.gl/1JvTvT
  29. Solensky R. Hypersensitivity reactions to beta-lactam antibiotics. Clin Revi Allerg Immu. 2003; 24: 201-220. Ref.: https://goo.gl/CGjKqb
  30. Macy E, Poon KY T. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med. 2009; 122: 1-7. Ref.: https://goo.gl/948w46
  31. Joint Task Force on Practice Parameters, American Academy of Alergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010; 105: 259-273.
  32. Shah NS, Ridgway JP, Pettit N, Fahrenbach J, Robicsek A. Documenting Penicillin Allergy: The Impact of Inconsistency. PLoS ONE. 2016; 11: e0150514. Ref.: https://goo.gl/mScXJD
  33. Macy E. How predictive is a history of penicillin allergy? JAMA. 2001; 286: 1174. Ref.: https://goo.gl/XxBMXj
  34. Wong BB, Keith PK, Waserman S. Clinical history as a predictor of penicillin skin test outcome. Ann Allergy Asthma Immunol. 2006; 97: 169-174. Ref.: https://goo.gl/HRcFRo
  35. Rubio M, Bousquiet PJ, Gomes E, Romano A, Demoly P. Results of d drug hypersensitivity evaluations in a large group of children and adults. Clin Exp Allergy. 2011; 42: 122-123. Ref.: https://goo.gl/Gju6Ns
  36. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk of Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemoth. 2012; 67: 742-748. Ref.: https://goo.gl/y1ifMy
  37. Weiss K. Clostridium difficile and fluoroquinolones: is there a link? Int J Antimicrob Agents. 2009; 33: 29-32. Ref.: https://goo.gl/DiAJ9g
  38. NHS Confederation. Key Statistics on the NHS. [Internet]. NHS confederation org. 2016 [cited on July 17, 2016]. Available from: Ref.: https://goo.gl/ZiqSQL
  39. Canadian Medical Association. Physician Data Centre: Canadian physician statistics. [Internet]. Canadian Medical Association. 2016 [cited July 17, 2010]. Ref.: https://goo.gl/EkY6UK
  40. Balekian DS, Banerji A, Blumenthal KG, Camargo CA, Long AA. Allergen immunotherapy: No evidence of infectious risk. J Allergy Clin Immunol. 2016; 137: 1887-1888. Ref.: https://goo.gl/s4oRqA


Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?